Skip to main content
Rheumatic Joint DiseaseChildren's healthBones and joints

What this study is

Continuation of the CARRA Registry as described in the protocol will support data collection on patients with pediatric-onset rheumatic diseases. The CARRA Registry will form the basis for future CARRA studies. In particular, this observational registry will be used to answer pressing questions about therapeutics used to treat pediatric rheumatic diseases, including safety questions.

Study details

Sponsor
Duke University
Conditions
Rheumatic Joint Disease
Enrolling
20,000 people
Starts
2015-07
Est. completion
2028-12
Record
View on ClinicalTrials.gov ↗